TY - JOUR
T1 - Effects of Azelastine on Neutrophil Chemotaxis, Phagocytosis and Oxygen Radical Generation
AU - Akamatsu, Hirohiko
AU - Miyachi, Yoshiki
AU - Asada, Yasuo
AU - Niwa, Yukie
PY - 1991/1
Y1 - 1991/1
N2 - The effects of azelastine, an orally active anti-allergic drug, on several inflammatory parameters of human neutrophils, including human neutrophil chemotaxis, phagocytosis and generation of reactive oxygen species (ROS), was examined. ROS generated in a cell-free, xanthine-xanthine oxidase system was also assessed. The species investigated were superoxide radical anion (O2), hydrogen peroxide (H2O2) and hydroxyl radical (OH-). Azelastine significantly inhibited human neutrophil phagocytosis and the generation of O2-, H2O2, OH. by human neutrophils. However, the drug did not markedly affect human neutrophil chemotaxis or the ROS levels generated in the xanthine-xanthine oxidase system. The present study indicates that azelastine may exert an anti-inflammatory action by inhibiting human neutrophil phagocytosis as well as oxygen radical generation at the sites of inflammation.
AB - The effects of azelastine, an orally active anti-allergic drug, on several inflammatory parameters of human neutrophils, including human neutrophil chemotaxis, phagocytosis and generation of reactive oxygen species (ROS), was examined. ROS generated in a cell-free, xanthine-xanthine oxidase system was also assessed. The species investigated were superoxide radical anion (O2), hydrogen peroxide (H2O2) and hydroxyl radical (OH-). Azelastine significantly inhibited human neutrophil phagocytosis and the generation of O2-, H2O2, OH. by human neutrophils. However, the drug did not markedly affect human neutrophil chemotaxis or the ROS levels generated in the xanthine-xanthine oxidase system. The present study indicates that azelastine may exert an anti-inflammatory action by inhibiting human neutrophil phagocytosis as well as oxygen radical generation at the sites of inflammation.
UR - http://www.scopus.com/inward/record.url?scp=0026340840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026340840&partnerID=8YFLogxK
U2 - 10.1254/jjp.57.583
DO - 10.1254/jjp.57.583
M3 - Article
C2 - 1687070
AN - SCOPUS:0026340840
SN - 0021-5198
VL - 57
SP - 583
EP - 589
JO - Journal of Pharmacological Sciences
JF - Journal of Pharmacological Sciences
IS - 4
ER -